Amjevita’s revenue was down 63% in the second quarter (Q2) compared with the first quarter of 2023, when the biosimilar launched. The reference product, Humira, still had net revenues in the United ...
The White House’s direct-to-consumer (DTC) platform, TrumpRx, is steadily expanding its catalogue, with products from GSK and Amgen the latest to join the collection of drugs offered through the ...
Amjevita (adalimumab-atto) is a brand-name drug prescribed for several inflammatory conditions in adults and some children. Amjevita comes as a solution for subcutaneous injection. The dosage can vary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results